businessbriefs
11:51in productionCh. 1 · The Claim/ 11:51 · ceiling 15 min
Scandals · Rise & fall

Theranos

2003

Theranos was not a startup that failed — it was a fraud that scaled.

Theranos claimed to replace central labs with portable, accurate, fingerstick blood testing. It did not. It used conventional machines. Its own devices produced unreliable results — so unreliable it voided two years of output. Federal regulators revoked its licence. Its founders were convicted of fraud. Its investors lost everything. Its story is not about ambition or disruption. It is about deception enabled by silence, deference, and misaligned incentives.

ScandalsRise & fallFraudScientific methodFailureFraud across the network →
Chapters & takeaways4
  1. 1:00
    The Claim

    Theranos’s entire value proposition rested on a false claim: that its Edison devices could run accurate, rapid blood tests from fingersticks.

  2. 3:01
    The Switch

    Theranos secretly ran most tests on conventional lab machines — hiding its inability to make its own devices work.

  3. 5:15
    The Collapse

    When exposed, Theranos voided two years of test results and lost its federal lab licence — ending its ability to operate clinically.

  4. 7:19
    The Accountability

    Regulatory failures preceded criminal convictions: state lab violations led to federal sanctions, then SEC charges and prison sentences.

Worth your time?

Yes. Study the whole thing.

1/ 5
What works
  • nothing at clinical or commercial scale
What does not
  • [1] (method) Theranos falsely claimed its blood tests were rapid, accurate, and required only tiny blood volumes using its own compact automated devices.
  • [2] (method) Theranos used traditional blood testing machines—not its Edison devices—to run tests, and its Edison machines may have produced inaccurate results.
  • [3] (result) Theranos voided two years of test results from its Edison device.
  • [5] (result) CMS revoked Theranos’s CLIA certificate and barred its owners from operating a clinical lab for two years.
Study it if
  • investors
  • regulators
  • journalists
Skip it if
  • patients
  • clinicians
  • lab technicians
The written brief1 min read

What the company or idea is

Theranos was a private US diagnostics company founded in 2003 that claimed to revolutionise clinical blood testing with proprietary miniaturised devices.

How it actually makes money

Theranos made no money. It raised over $700 million from investors but generated no revenue from its claimed technology.

What works

Nothing worked at scale. Its core technology failed validation. Its lab operations violated federal and state standards. Its business model collapsed because its product did not exist.

What does not

Its Edison devices did not perform accurate, rapid, fingerstick blood tests. They were not used for most testing. They produced unreliable results — so unreliable that Theranos voided two years of their output.

What to take from it

A company can scale perception far beyond capability when investors reward narrative over verification — and when regulators lack capacity or mandate to intervene early.

Is it worth your time

Yes. It is a textbook case of how regulatory failure, media deference, and venture capital incentives enable systemic fraud in health tech.

Same desk · Scandals4 of 22
9:47
WorldCom scandalWorldCom was a telecommunications company whose collapse resulted from systematic, top-down accounting fraud — 49 identical, undocumented journal entries that shifted $3.8 billion in operating expenses to the balance sheet as capital expenditures. This inflated assets by over $11 billion and turned a $395 million loss into a $130 million profit for Q1 2002. The fraud was uncovered by Cynthia Cooper’s internal audit unit — not external auditors or regulators. It exposed how financial reporting can be weaponised when controls are overridden and documentation abandoned.
11:27
GSK plcHenry Wellcome · 2000GSK plc is a British multinational pharmaceutical and biotechnology company formed in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham. It traces its origins to Henry Wellcome’s 1880 co-founding of Burroughs Wellcome & Company. GSK developed the first malaria vaccine (RTS,S), markets WHO-listed essential medicines, and reported $42.4 billion in revenue and $9.32 billion in earnings in 2025. In 2012, it pleaded guilty in the US to unlawful drug promotion, failure to report safety data, and physician kickbacks — agreeing to a $3 billion settlement, the largest healthcare fraud case in US history and the largest in the pharmaceutical industry. The Wellcome Foundation Ltd., established by Henry Wellcome in 1924, was later sold to GSK following changes in UK charity law.
10:50
Elizabeth Holmes1984Theranos was not a diagnostic company. It was a narrative vehicle — funded, regulated, and marketed as if it were one.
10:15
TheranosElizabeth Holmes · 2003Theranos was a health technology company founded in 2003 in Palo Alto, California, that falsely claimed to perform rapid, accurate blood tests using minimal blood volume via proprietary devices; investigations revealed it relied on conventional machines, produced inaccurate results, voided two years of Edison data, and misrepresented its capabilities to investors, partners, and regulators.
Up next in Business

Family tree of Thomson family

Thomson family · 9:58

A peerage isn’t decoration — it’s the operating system for Canada’s wealthiest family.

Play nextBack to Scandals
9:58